Karyopharm Therapeutics
KPTI
KPTI
89 hedge funds and large institutions have $610M invested in Karyopharm Therapeutics in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
+4
Holders Change %
+4.71%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
41
Reduced
18
Closed
12
Calls
$2.86M
Puts
$4.16M
Net Calls
-$1.3M
Net Calls Change
+$460K
Top Buyers
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$21.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.6M |
| 3 |
Millennium Management
New York
|
+$7.3M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.72M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.31M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$8.23M |
| 2 |
CGI
CI Global Investments
Oakland,
California
|
-$6.12M |
| 3 |
PC
PointState Capital
New York
|
-$4.59M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.84M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.7M |
